Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 8 | 2022 | 30 | 3.330 |
Why?
|
| Fontan Procedure | 5 | 2022 | 8 | 2.220 |
Why?
|
| Cardiac Catheterization | 9 | 2018 | 88 | 1.770 |
Why?
|
| Heart Septal Defects, Atrial | 3 | 2018 | 16 | 1.580 |
Why?
|
| Ultrasonography, Interventional | 4 | 2014 | 63 | 1.400 |
Why?
|
| Heart Ventricles | 8 | 2018 | 170 | 1.320 |
Why?
|
| Ultrasonography, Prenatal | 5 | 2017 | 22 | 1.290 |
Why?
|
| Echocardiography | 7 | 2018 | 171 | 1.240 |
Why?
|
| Mammary Arteries | 2 | 2018 | 5 | 1.240 |
Why?
|
| Hypoplastic Left Heart Syndrome | 3 | 2017 | 6 | 0.910 |
Why?
|
| Tertiary Care Centers | 2 | 2013 | 66 | 0.900 |
Why?
|
| Heart Block | 2 | 2017 | 19 | 0.760 |
Why?
|
| Tachycardia | 1 | 2018 | 48 | 0.670 |
Why?
|
| Embolization, Therapeutic | 1 | 2018 | 26 | 0.650 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2009 | 44 | 0.640 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2017 | 1 | 0.640 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2017 | 3 | 0.640 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2017 | 8 | 0.640 |
Why?
|
| Echocardiography, Doppler, Color | 4 | 2013 | 13 | 0.630 |
Why?
|
| Child, Preschool | 7 | 2018 | 641 | 0.620 |
Why?
|
| Feces | 1 | 2017 | 98 | 0.610 |
Why?
|
| Coronary Sinus | 1 | 2017 | 3 | 0.610 |
Why?
|
| Vascular System Injuries | 1 | 2017 | 5 | 0.610 |
Why?
|
| Septal Occluder Device | 1 | 2017 | 17 | 0.600 |
Why?
|
| Female | 19 | 2022 | 16211 | 0.580 |
Why?
|
| Coronary Disease | 2 | 2014 | 86 | 0.580 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2017 | 89 | 0.570 |
Why?
|
| Humans | 27 | 2022 | 29361 | 0.570 |
Why?
|
| Child | 8 | 2022 | 1345 | 0.560 |
Why?
|
| Prenatal Diagnosis | 2 | 2013 | 15 | 0.540 |
Why?
|
| Infant, Newborn | 7 | 2018 | 604 | 0.540 |
Why?
|
| Heart Atria | 4 | 2018 | 74 | 0.510 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2014 | 7 | 0.500 |
Why?
|
| Pulmonary Valve | 1 | 2014 | 8 | 0.500 |
Why?
|
| Echocardiography, Doppler | 1 | 2014 | 19 | 0.500 |
Why?
|
| Heart Valve Prosthesis | 1 | 2014 | 22 | 0.500 |
Why?
|
| Heart Neoplasms | 1 | 2014 | 13 | 0.500 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2014 | 22 | 0.500 |
Why?
|
| Osteosarcoma | 1 | 2014 | 29 | 0.490 |
Why?
|
| Pregnancy | 5 | 2014 | 404 | 0.490 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2013 | 3 | 0.470 |
Why?
|
| Fetal Heart | 1 | 2013 | 2 | 0.470 |
Why?
|
| Pentalogy of Cantrell | 1 | 2013 | 1 | 0.460 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2013 | 9 | 0.460 |
Why?
|
| Ventricular Function | 1 | 2013 | 14 | 0.460 |
Why?
|
| Bone Neoplasms | 1 | 2014 | 102 | 0.450 |
Why?
|
| Myocardial Contraction | 1 | 2013 | 75 | 0.440 |
Why?
|
| Male | 17 | 2018 | 15637 | 0.440 |
Why?
|
| Levocardia | 1 | 2012 | 1 | 0.440 |
Why?
|
| Balloon Occlusion | 2 | 2009 | 6 | 0.400 |
Why?
|
| Femur | 1 | 2014 | 398 | 0.390 |
Why?
|
| Retrospective Studies | 8 | 2018 | 3273 | 0.370 |
Why?
|
| Diagnostic Imaging | 2 | 2014 | 90 | 0.360 |
Why?
|
| Radiography, Interventional | 1 | 2008 | 24 | 0.340 |
Why?
|
| Adolescent | 6 | 2022 | 2280 | 0.340 |
Why?
|
| Treatment Outcome | 6 | 2018 | 3476 | 0.330 |
Why?
|
| Diagnosis, Differential | 4 | 2014 | 389 | 0.320 |
Why?
|
| Coronary Circulation | 3 | 2014 | 43 | 0.290 |
Why?
|
| Infant | 4 | 2018 | 531 | 0.290 |
Why?
|
| Heart Failure | 3 | 2014 | 204 | 0.280 |
Why?
|
| Coronary Artery Bypass | 2 | 2016 | 32 | 0.270 |
Why?
|
| Palliative Care | 2 | 2017 | 145 | 0.250 |
Why?
|
| Follow-Up Studies | 4 | 2015 | 1829 | 0.240 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2014 | 9 | 0.240 |
Why?
|
| Exercise Tolerance | 1 | 2022 | 33 | 0.210 |
Why?
|
| Myocytes, Cardiac | 2 | 2014 | 180 | 0.210 |
Why?
|
| Oxygen | 1 | 2022 | 85 | 0.210 |
Why?
|
| Exercise Test | 1 | 2022 | 122 | 0.200 |
Why?
|
| Ventricular Function, Left | 2 | 2018 | 44 | 0.190 |
Why?
|
| Adult | 4 | 2017 | 8604 | 0.180 |
Why?
|
| Young Adult | 3 | 2017 | 1935 | 0.180 |
Why?
|
| Pulmonary Artery | 2 | 2017 | 43 | 0.170 |
Why?
|
| Tetralogy of Fallot | 1 | 2018 | 3 | 0.170 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2018 | 40 | 0.160 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 965 | 0.160 |
Why?
|
| Atrial Pressure | 1 | 2017 | 1 | 0.160 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2017 | 6 | 0.160 |
Why?
|
| Vascular Resistance | 1 | 2017 | 11 | 0.160 |
Why?
|
| Hemodynamics | 3 | 2018 | 83 | 0.150 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2017 | 2 | 0.150 |
Why?
|
| Equipment Design | 2 | 2008 | 185 | 0.150 |
Why?
|
| Stents | 2 | 2015 | 76 | 0.150 |
Why?
|
| Alprostadil | 1 | 2017 | 10 | 0.150 |
Why?
|
| Biomarkers | 2 | 2017 | 692 | 0.150 |
Why?
|
| Quality of Life | 1 | 2022 | 664 | 0.150 |
Why?
|
| Infant, Premature | 1 | 2018 | 178 | 0.150 |
Why?
|
| Preoperative Care | 1 | 2018 | 135 | 0.150 |
Why?
|
| Heart Transplantation | 1 | 2017 | 38 | 0.150 |
Why?
|
| Prosthesis Implantation | 1 | 2017 | 33 | 0.150 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 123 | 0.150 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2016 | 4 | 0.140 |
Why?
|
| Coronary Vessels | 1 | 2016 | 46 | 0.140 |
Why?
|
| Norwood Procedures | 1 | 2015 | 4 | 0.140 |
Why?
|
| Collateral Circulation | 1 | 2014 | 7 | 0.130 |
Why?
|
| Diverticulum | 1 | 2014 | 3 | 0.130 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2014 | 34 | 0.130 |
Why?
|
| Heart Aneurysm | 1 | 2014 | 6 | 0.130 |
Why?
|
| Ventricular Septum | 1 | 2014 | 2 | 0.130 |
Why?
|
| Excitation Contraction Coupling | 1 | 2014 | 23 | 0.130 |
Why?
|
| Terminology as Topic | 1 | 2014 | 48 | 0.120 |
Why?
|
| Fatal Outcome | 1 | 2014 | 59 | 0.120 |
Why?
|
| Urocortins | 1 | 2014 | 3 | 0.120 |
Why?
|
| NFATC Transcription Factors | 1 | 2014 | 15 | 0.120 |
Why?
|
| Electrocardiography | 2 | 2012 | 209 | 0.120 |
Why?
|
| Biopsy | 1 | 2014 | 234 | 0.120 |
Why?
|
| Pharmacopoeias as Topic | 1 | 2012 | 2 | 0.110 |
Why?
|
| Reference Values | 1 | 2013 | 227 | 0.110 |
Why?
|
| Cardiovascular Agents | 1 | 2012 | 28 | 0.110 |
Why?
|
| Calcium Signaling | 1 | 2014 | 174 | 0.110 |
Why?
|
| Pediatrics | 1 | 2012 | 33 | 0.110 |
Why?
|
| Abnormalities, Multiple | 1 | 2012 | 14 | 0.110 |
Why?
|
| Cohort Studies | 1 | 2017 | 1939 | 0.110 |
Why?
|
| Heart Diseases | 1 | 2012 | 73 | 0.100 |
Why?
|
| Prosthesis Design | 1 | 2014 | 502 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 333 | 0.100 |
Why?
|
| Hypertension, Pulmonary | 1 | 2010 | 17 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 770 | 0.090 |
Why?
|
| Dilatation, Pathologic | 1 | 2009 | 7 | 0.090 |
Why?
|
| Cardiomyopathies | 1 | 2009 | 29 | 0.090 |
Why?
|
| Tachycardia, Ventricular | 1 | 2009 | 34 | 0.090 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2009 | 9 | 0.090 |
Why?
|
| Heart Valve Diseases | 1 | 2009 | 22 | 0.090 |
Why?
|
| Cineangiography | 1 | 2008 | 3 | 0.090 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2009 | 47 | 0.090 |
Why?
|
| Forecasting | 1 | 2009 | 117 | 0.080 |
Why?
|
| Coronary Angiography | 1 | 2008 | 91 | 0.080 |
Why?
|
| Phlebography | 1 | 2007 | 9 | 0.080 |
Why?
|
| Aortography | 1 | 2007 | 10 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 553 | 0.080 |
Why?
|
| Pulmonary Veins | 1 | 2007 | 23 | 0.080 |
Why?
|
| Middle Aged | 2 | 2013 | 9823 | 0.070 |
Why?
|
| Feasibility Studies | 1 | 2007 | 227 | 0.070 |
Why?
|
| Disease Progression | 1 | 2009 | 788 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2009 | 678 | 0.070 |
Why?
|
| Rabbits | 2 | 2014 | 283 | 0.060 |
Why?
|
| Time Factors | 1 | 2007 | 1618 | 0.060 |
Why?
|
| Animals | 3 | 2014 | 4577 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2018 | 42 | 0.040 |
Why?
|
| Aortic Coarctation | 1 | 2017 | 2 | 0.040 |
Why?
|
| Telemetry | 1 | 2017 | 11 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2017 | 76 | 0.040 |
Why?
|
| Vascular Surgical Procedures | 1 | 2015 | 24 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2014 | 36 | 0.030 |
Why?
|
| History, 19th Century | 1 | 2014 | 66 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2014 | 84 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2014 | 17 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 48 | 0.030 |
Why?
|
| Aged | 1 | 2007 | 9447 | 0.030 |
Why?
|
| Length of Stay | 1 | 2015 | 317 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 56 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2014 | 101 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 521 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2014 | 676 | 0.030 |
Why?
|
| Cardiology | 1 | 2012 | 72 | 0.030 |
Why?
|
| Disease Management | 1 | 2012 | 114 | 0.030 |
Why?
|
| Prognosis | 1 | 2014 | 840 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2014 | 483 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 726 | 0.020 |
Why?
|
| Calcium | 1 | 2014 | 495 | 0.020 |
Why?
|
| Epicardial Mapping | 1 | 2009 | 3 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2010 | 65 | 0.020 |
Why?
|
| Lung | 1 | 2010 | 154 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 2009 | 78 | 0.020 |
Why?
|